Normal BMI, Obesity? Shocking New Cutoff

Your doctor may have told you that your weight is perfectly fine, but a major new study suggests that for one in four people with a normal body mass index, that reassurance could be dangerously wrong.

Quick Take

A new study published in the Annals of Internal Medicine found that 26% of adults with a normal body mass index actually meet criteria for clinical obesity.
More than half of adults in the overweight body mass index range also qualify as clinically obese under the updated definition.
The new framework looks beyond weight-to-height ratios to include body fat distribution, waist circumference, and evidence of organ dysfunction.
Body mass index has long been criticized for missing hidden metabolic risk, and this study puts hard numbers on exactly how large that blind spot is.

The Number That Should Alarm Your Doctor

The study, published in the Annals of Internal Medicine, examined a large United States cohort and found that 26% of adults with a body mass index between 18.5 and 24.9, the range officially classified as healthy weight by the Centers for Disease Control and Prevention, met the criteria for clinical obesity ^[1]. More striking still, over 50% of adults in the overweight body mass index range of 25 to 29.9 also qualified ^[1]. These are not marginal cases on a statistical edge. These are tens of millions of Americans walking around believing they have been cleared.

The researchers at Mass General Brigham applied a definition of obesity that moves beyond the familiar height-and-weight ratio to include measures of body fat distribution and whether excess fat is actually impairing organ function or limiting daily activity ^[3]. That shift in definition is not a minor tweak. It changes who gets flagged, who gets treated, and who gets sent home with a clean bill of health that may not be accurate.

Why Body Mass Index Was Always a Blunt Instrument

Body mass index was never designed to be a clinical diagnostic tool. It was developed in the 19th century as a population-level statistical measure, and its migration into individual clinical practice has always carried limitations. The Centers for Disease Control and Prevention acknowledges that body mass index cannot distinguish between lean muscle mass and fat mass ^[9]. A muscular athlete and a sedentary person with significant visceral fat can share an identical body mass index reading. The American Medical Association noted in 2023 that further measures beyond body mass index are recommended for clinical use ^[8].

The danger zone that body mass index consistently misses is visceral fat, the deep abdominal fat that wraps around organs and drives metabolic disease. In women, a waist circumference exceeding 88 centimeters signals elevated risk regardless of what the scale says or what the body mass index calculation produces ^[2]. This phenotype, sometimes called metabolically unhealthy normal weight, has been discussed in research circles for years, but this new study quantifies its prevalence at a scale that is genuinely difficult to ignore.

A New Definition With Real Clinical Consequences

The updated clinical obesity framework, informed by a Lancet Commission definition, diagnoses obesity when there is evidence of reduced organ or tissue function attributable to excess adiposity, or when substantial age-adjusted limitations in daily activities are present ^[7]. Critically, the framework still acknowledges that a body mass index above 40 is sufficient on its own to assume clinically significant excess fat, so it does not discard body mass index entirely ^[7]. What it does is reposition body mass index as a screening input rather than a final verdict, which is exactly where the evidence has been pointing for years.

NEW: A study found that many adults who fall into “normal” or “overweight” #BMI categories may still meet criteria for clinical #obesity, a broader term that combines body measurements with evidence of obesity-related health conditions. The findings highlight the limitations of… pic.twitter.com/i2wMmhKfjT

— Annals of Int Med (@AnnalsofIM) June 2, 2026

The practical implication is not trivial. A person with a normal body mass index who also carries excess abdominal fat and shows early signs of metabolic dysfunction, elevated blood pressure, insulin resistance, or reduced kidney function, may now qualify for interventions that were previously reserved for people with higher body mass index readings ^[6]. Whether the healthcare system is prepared to act on that expanded definition, or whether insurers will cover the resulting diagnoses and treatments, is a separate and thorny question that the research does not answer.

The Goalposts Moved, But They Moved in the Right Direction

Critics of the new definition will argue that expanding the clinical obesity category to capture more people risks medicalizing normal variation and straining an already overburdened system. That concern deserves a fair hearing. But the counterargument is harder to dismiss: if a quarter of people currently told they are healthy actually carry clinically meaningful obesity-related risk, the existing system is not protecting them. It is simply not looking hard enough. A screening tool that misses one in four cases at the supposedly safe end of the scale is not a tool you want making final calls about patient health. The body mass index served a purpose. This research makes clear that purpose has limits, and those limits have consequences.